Prenatal Administration of Betamethasone and Neonatal Respiratory Distress Syndrome in Multifetal Pregnancies: A Randomized Controlled Trial

Abbasalizadeh F., Pouya K., Zakeri R., Asgari-Arbat R., Abbasalizadeh S., Parnianfard N.

CURRENT CLINICAL PHARMACOLOGY, vol.15, no.2, pp.164-169, 2020 (ESCI, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 2
  • Publication Date: 2020
  • Doi Number: 10.2174/1574884714666191007154936
  • Journal Name: CURRENT CLINICAL PHARMACOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Agricultural & Environmental Science Database, Biotechnology Research Abstracts, EMBASE, MEDLINE
  • Page Numbers: pp.164-169
  • Keywords: Neonatal respiratory distress syndrome, multifetal pregnancies, betamethasone, antenatal corticosteroid, clinical trial, gestation, INFANTS, CORTICOSTEROIDS, GESTATION, SINGLETON, OUTCOMES
  • Ankara University Affiliated: Yes

Abstract

Background: Neonatal Respiratory Distress Syndrome (NRDS) is one of the most frequent causes of neonatal mortality especially in premature infants. Although it has been well established that maternal antenatal corticosteroid therapy has a positive effect on NRDS reduction, yet the effectiveness of this treatment in multifetal pregnancies is dubious.